Pentose shunt, glucose-6-phosphate dehydrogenase, NADPH redox, and stem cells in pulmonary hypertension

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Redox signaling plays a critical role in the pathophysiology of cardiovascular diseases. The pentose phosphate pathway is a major source of NADPH redox in the cell. The activities of glucose-6-phosphate dehydrogenase (the rate-limiting enzyme in the pentose shunt) and glucose flux through the shunt pathway is increased in various lung cells including, the stem cells, in pulmonary hypertension. This chapter discusses the importance of the shunt pathway and glucose-6-phosphate dehydrogenase in the pathogenesis of pulmonary artery remodeling and occlusive lesion formation within the hypertensive lungs.

Cite

CITATION STYLE

APA

Hashimoto, R., & Gupte, S. (2017). Pentose shunt, glucose-6-phosphate dehydrogenase, NADPH redox, and stem cells in pulmonary hypertension. In Advances in Experimental Medicine and Biology (Vol. 967, pp. 47–55). Springer New York LLC. https://doi.org/10.1007/978-3-319-63245-2_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free